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TW O types of interaction are integrated in a biological system between the cells of the 
microbic invaders, on the one hand, and the drug 
that is introduced into the system to combat them, 
on the other. The first type is basically physical 
and the second chemical. Illustrative of the for­
mer are such phenomena as osmosis, diffusion, 
hydration, dehydration, solution, adsorption, cor­
rosion and altered surface tension; while illus­
trative of the latter are such phenomena as 
precipitation, absorption, oxidation, reduction, fu­
sion and disintegration. In a general sense the 
action of alkaloids simulates the former sort of 
interaction in which the drug bombards and after 
performing its action, is then released and elimi­
nated unchanged; whereas the action of glyco­
sides simulates the latter. In this instance chemical 
interaction between the constituent molecules oc­
curs and as a consequence one or more of the 
above-named chemical changes takes place. Disin­
tegration of the drug molecule and arrest or death 
of the invading cells with a sparing of the body 
cells result if the remedial drug is efficacious as it 
would be at therapeutic levels; while destruction 
of the cells of the host may ensue at toxic levels.
Until the time of Schmiedeberg, confusion 
reigned with regard to an appreciation of these 
fundamental emphases; and, as a result the for­
tunes of pharmacology rested insecurely in the 
empirical hands of the clinician. As Henri Berg­
son, in his "Creative Evolution" said of the phi­
losopher that he can focus upon and clarify but 
one of the manifold facets of the cosmic jewel in 
his lifetime so it seems in science that only in 
exceptional cases are more vistas than one, of the
* Presented at the scientific session of the Third Medi­
cal Reading Club of The District of Columbia, Wash­
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unknown at the periphery of nature’s known, ex­
plored by any single investigator. With nothing 
more than dim adumbrations of the chemical ap­
proach men like Schmiedeberg, Bernard and 
Cushny have traversed the first pathway and ex­
ploited its rich resources until Pasteur, Koch and 
Lister came upon the scene bringing with them 
instruments that were right then being hammered 
out on the anvil of a dawning creative chemistry. 
The chemical approach to pharmaco-dynamic en­
terprises came to full-bloom in the brilliant re­
searches of Ehrlich; and chemotherapy has since 
become an intriguing adventure in the study of 
the drug-host-invader complex. Ehrlich directed 
his attack on trypanosomiasis with the arsenicals. 
Then came Sazerac and Levaditi in their experi­
ments with bismuth on the trepanema pallidium. 
The theoretical basis of Ehrlich’s historic achieve­
ments is quite well known to students of im­
munology. Equipped with certain structural con­
figurations complimentary to those of the invading 
micro-organism the drug in question is supposed 
to attach itself to the invader acting thereby as 
substitute for the cells of the host; and by means 
of this selective chemical affinity the host is spared. 
The therapeutic-toxic ratio of a chemotherapeutic 
agent is enhanced if and when, in addition to 
engaging the attachment mechanism of the in­
vader, the drug is capable also of stimulating the 
body cells to the production of "receptors," or 
antibodies which may be thrown into the circula­
tion; the proliferation of the reticuloendothelial 
cells; and the mobilization of the other phago­
cytic systems of the body to offer added protection 
to the host. Ehrlich’s hypothesis postulated com­
plete sterilization with but a few doses. But while 
interesting, this was an eventuality which, un­
fortunately, actual experience failed to validate.
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The most illuminating modification of Ehrlich’s 
view is that propounded by Voegtlin and Smith1 
and Voegtlin, Dyer and Leonard.2 According to this 
group of investigators the inactive arsenical rep­
resented by the formula R— As =  As— R is par­
tially oxidized to form arsenoxide (R— As =  0 )  
in the system and this substance as such exercises 
lethal effects on the parasites. Subsequently, these 
and numerous other investigators have found that 
in the presence of the new chemical the defense 
mechanisms of the body are apt to be markedly 
increased, c.f., Cooper and Tatum.3 With varia­
tions in specific emphases these modifications lie 
back of all modern approaches to problems in 
chemotherapy. The added features seem to serve 
as the determinative factors differentiating a 
chemotherapeutic from an antiseptic agent.
The history of the preparation of the sulfona­
mides dates as far back as thirty-five years in spite 
of the fact that their definitive utilization as 
chemotherapeutic agents is but a matter of a few 
years. Regarding their preparation Goodman and 
Gilman4 state: "In 1909, Hoerlein and coworkers, 
of the I.G. Farbenindustrie, synthesized the first 
azo dyestuffs containing sulfonamide and substi­
tuted sulfonamide groups and noted them to be 
superior in color-fastness to similar dyes without 
the sulfonamide group. The firm combination 
which the complex azo dyes formed with the pro­
teins of wool and silk suggested the possibility 
that these agents might react with bacterial proto­
plasm, and in 1913 Eisenberg discovered the 
bactericidal action in vitro of chrysoidine and 
suggested its use in chemotherapy. In the follow­
ing year, Tchichibabin and Zeide (1914) synthe­
sized a red dye, pyridium, from chrysoidin, which 
subsequently was to be introduced as a urinary 
antiseptic (Ostromyslensky, 1926). In the years 
immediately following, scarlet red, another azo 
dye, came into prominence and chemical advances 
in the synthesis of azo dye derivatives of cupreines 
were made by Jacobs and Heidelberger (1917) 
and Heidelberger and Jacobs (1 9 1 9 ). The same 
investigators also prepared para amino benzene 
sulfonamide according to the method of Gelmo 
and postulated that this substance would be lib­
erated by the breakdown in the tissues of sulfona- 
mido chrysoidin. Although they commented on 
the high bactericidal potency of their compounds, 
unfortunately the work was not continued. In
1930, another azo compound known as serenium 
(2— 4 diamino 4— ethoxy azo benzene) was intro­
duced by Ostromyslensky as a urinary antiseptic.”
In his attempt at clarifying the conceptual differ­
ence between antisepsis and chemotherapy, Rene 
Dubos3 states: "It appears that the typical anti­
septic behaves as a gross protoplasmic poison de­
stroying the general . . . cellular mechanisms. On 
the contrary, most chemotherapeutic agents have 
a very selective effect on some specific metabolic 
steps.”
In this report we shall consider two of the more 
recent groups of chemotherapeutic agents. Illus­
trative of drugs belonging in the first category are 
the sulfonamides of which prontosil, neo-pronto- 
sil, sulfanilamide, sulfapyridine, sulfathiazole, sul­
fadiazine, sulfaguanadine, succynil sulfathiazole 
(sulfasuccidine) and sulfamerizine are types; 
while illustrative of drugs belonging in the second 
category are penicillin and various other metabo­
lites or so-called antibiotics extracted from bacteria, 
fungi and other biological material. The chief rep­
resentatives of the group are penicillin, gramicidin, 
tyrocidin, tyrothricin, actinomycin, proactinomy­
cin, citrinin, streptothricin, gliotoxin, fumigacin, 
clavicin, lactonin, and lysozyme.
In 1933 Foerster6 administered prontosil to an 
infant suffering with streptococcic septicemia and 
experienced a dramatic cure. However, it was not 
until 1935 that Domagk7 proposed the introduc­
tion of prontosil and prontosil soluble into clinical 
medicine. In the body these dyes break down to 
para amino benzene sulfonamide which latter sub­
stance was found by the Trefouels, Nitti and 
Bovet8 to constitute their active principle. Then 
it was that Fourneau9 and his associates at the 
Pasteur Institute8 began preparing sulfanilamide 
which with the other derivatives subsequently pro­
duced is widely employed in clinical medicine.
Early investigtaions by Zahl, Hunter and 
Cooper10 have firmly established the fact that in 
varying degrees the sulfonamides confer limited 
protection against the lethal action of endotoxins 
of numerous gram-negative organisms in general 
without interfering with their immunizing proc­
esses. Specifically the sulfonamides have been em­
ployed to clinical advantage in the treatment of 
infections from beta-hemolytic streptococcus es­
pecially in puerperal fever, erysipelas, septicemia, 
meningococcic sore throat, surgical infections with
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gram-negative organisms, and also in gonococcic, 
typhoid and paratyphoid and all types of Bru­
cella infections. When employed with the specific 
anti-serum the results in pneumococcic, meningo- 
coccic and streptococcic infections are better than 
the results with either form of therapy alone. In 
an investigation of this adjuvant action Long and 
Bliss11 state that while the sulfonamide drugs pre­
vent the growth and spread of the invading micro­
organism, the serum neutralizes the toxic products 
of their growth. As such they may be said to be 
complimentary; in that, by restricting growth the 
sulfonamides limit the quantity of toxic substances 
produced and thereby help to mitigate, if not to 
abort, the toxemia, fever and rash which those 
toxic substances are calculated to produce.
In a report on the mechanism of action of the 
sulfonamides, ^Schmelkes and his associates1- indi­
cate that the efficiency of this class of compounds 
increases with their increasing alkalinity from pH 
values above 7 in the direction of 9. On this 
point, however, there is as yet a lack of general 
agreement. Cases of clinical acidosis resulting 
from their employment have been reported by 
numerous investigators, Long and Bliss,1*'1 Strauss 
and Southworth,14 Towsley and Engelfried,ir> and 
Beckman.10 This acidosis appears to be the result 
of an increase in the renal excretion of sodium 
and potassium due, apparently, to a loss of effi­
ciency in the reabsorption capacity of the tubular 
epithelium with respect to fixed bases; and associ­
ated with a decrease in the carbon-dioxide com­
bining power of the plasma.
Occasionally, when this acidosis remains un­
compensated, there develops a definite hyperpnea. 
As a consequence the proponents of this school of 
thought advocate the concurrent administration of 
sodium bicarbonate.
Over against this approach to the problem there 
is the position taken by such investigators as Hart­
mann, Perley and Barnett.17 These men hold that 
in sulfonamide medication there occurs a loss of 
serum carbon dioxide which results in an alkaline 
shift of the serum; and the kidney seeks to correct 
this imbalance by excreting an alkaline urine. 
With this explanation hyperpnea falls in line with 
the loss of serum carbon dioxide. As such, the 
exhibition of a hyperventilation alkalosis should 
therefore serve as a contraindication to the routine 
use of sodium bicarbonate. They insist that under
appropriate conditions the administration of so­
dium bicarbonate might cause an uncompensated 
alkalosis. In support of this contention Hartmann18 
induced an acid excess type of acidosis by ad­
ministering ammonium chloride to a normal sub­
ject. But this acidosis was equilibrated by tubular 
reabsorption of the urinary sodium bicarbonate. 
When this was followed by the administration of 
sulfanilamide the urinary excretion was not alka­
line. To Hartmann18 this was convincing evidence 
that tubular reabsorption of sodium bicarbonate is 
elicitable when changes in the acid-base balance 
demand such reabsorption. Beckman and his associ­
ates10 have since then reinvestigated the problem. 
Their findings are that sulfanilamide causes a loss 
of sodium in the urine and a smaller loss of potas­
sium but with no loss of chloride. They conclude 
that sulfanilamide hyperpnea is an event second­
ary and complimentary to depletion of plasma 
bicarbonate resulting from the loss of fixed bases 
in the urine and that the associated acidosis is an 
expression of the body’s alkali deficit. The dis­
turbance, they say, is of only minor clinical sig­
nificance and is correctible by an adequate intake 
of sodium chloride. The correct electrolytic pattern 
is thereby maintained and there obtains a func­
tional adjustment of the renal activity.
The mechanism of action of the sulfonamides 
in combination with urea is also intriguing. Tan- 
nenbert and his associates-0 have made the ob­
servation that organisms rendered resistant to the 
sulfonamides by para-amino benzoic acid were 
again rendered susceptible when urea was given 
with the sulfonamide in question; and this, even 
in the presence of the chemical inhibitor. They 
have found, also, that staphylococci which are 
resistant to sulfathiazole have showed suscepti­
bility to a combination of sulfathiazole and urea. 
The action of urea in this connection is not dis­
similar to that of azochloramid and such purine 
bodies as hypo-xanthine and adenine, which, when 
used in combination with the sulfonamides even in 
the presence of the inhibtor render the sulfona­
mide bacteriostatic. The final explanation as to 
whether or not this similarity of action is based 
on the same mechanism, and what the mechanism 
is, is still being sought.
At the borderline between bacterium and virus 
there hovers an aura of haziness regarding the 
functional efficiency of the sulfonamides. The
I
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problems that arise and might arise in this area 
of indefiniteness seem destined by their clarifica­
tion to make for a concurrent re-classification of 
the virus diseases. It has been demonstrated by 
Findley21 and Jones and his coworkers22 that sul- 
fathiazole and sulfadiazine are both effective 
against the virus of lymphogranuloma venereum. 
Since it is true that the sulfonamides are effective 
against but a few of the virus or virus-like diseases 
it has been felt that insight gained into this differ­
ential effectiveness might indirectly offer some clue 
to the mechanism of action of these compounds. 
Accordingly Rake, Jones and Nigg23 have carried 
out a series of experiments using these two sul­
fonamide compounds in mouse pneumonitis. These 
investigators found that sulfathiazole and sulfa­
diazine are even more effective in this disease than 
they are in lymphogranuloma venereum. On the 
other hand neither compound has showed sig­
nificant effectiveness against meningo-pneumonitis 
in mice. The etiologic agents of lymphogranuloma 
venereum and mouse pneumonitis are strikingly 
susceptible to the sulfonamides; as also are the 
agents that produce trachoma, inclusion blenor- 
rhea and "heart-water” fever. These are classed 
with the rickettsiae. But most of the other virus 
agents are not so classified today. Meanwhile, evi­
dence is accumulating which tends to separate the 
lymphogranuloma venereum-psitticosis group from 
the true virus diseases. All investigations thus far 
have failed to establish any effectiveness of the 
sulfonamides against the true viruses.
THE PENICILLIN GROUP
The mould penicillium notatum produces a sub­
stance which exerts a powerful inhibitive action 
against gram-positive bacteria, both rods and cocci. 
In vitro experiments have occasionally demon­
strated such action in dilutions as weak as one in 
one billion. Streptococci are inhibited in dilutions 
of 1:25,000,000 and some preparations of pencil- 
lin have exhibited activity, according to Bloomfield, 
Rantz and Kirby24 in dilutions of 1:100,000,000. 
Against gram-negative cocci inhibitive action is 
also demonstrable but only in considerably higher 
strengths, 1:1,000 for instance. Anaerobic organ­
isms, also, and even the treponema pallidum show 
varying degrees of susceptibility to penicillin. 
Powell and Jamieson25 found this antibiotic an 
effective agent against sulfonamide-fast pneumo­
cocci in mice, and Dawson and Hobby26 speak for 
its efficacy, clinically, in patients who show a pro­
hibiting sensitivity to sulfonamide therapy, and 
also in patients with marked renal insufficiency 
and secondary anemia, in both of which conditions 
the sulfonamides are usually contraindicated. For 
staphylococcic infections penicillin is a happy dis­
covery in that while being remarkably refractory 
to the sulfonamides the organism is highly sen­
sitive to penicillin. A therapeutic agent of such 
high and wide effectiveness must, of necessity, 
arouse intense toxicological interest since, as is 
not infrequently the case with very active agents, 
the therapeutic-toxic coefficient is sometimes pro­
hibitively narrow. In this particular respect peni­
cillin represents a striking exception. Penicillin is 
remarkably non-toxic to cells of animal tissues. 
Summarizing many "isolated reports” Dubos5 in­
dicates that it affects neither their growth nor 
metabolism; and Dawson and Hobby26 supporting 
the thought state that: "a variety of experimental 
observations have indicated that penicillin is com­
pletely devoid of toxic effects in concentrations 
far beyond those necessary for therapeutic pur­
poses.” In addition, these investigators point out 
that: "prolonged administration has not led to the 
development of any intolerance or sensitivity . . . 
or cumulative effect . . . (nor has) the infecting 
strain showed . . . evidence of becoming resistant 
to the action of penicillin.”
On the other hand, tyrothricin, the original 
crude gramicidin obtained from bacillus brevis 
which yields two other active substances, grami­
cidin and tyrocidin when purified, while exhibit­
ing marked action against both gram-positive and 
gram-negative bacteria completely inhibits the oxy­
gen consumption of bovine spermatozoa and also 
their motility in acid Ringer’s phosphate and 
Ringer’s bicarbonate solutions. Tolerance to this 
agent is readily acquired by staphylococci; and, 
with tolerance, a correlevant reduction of its 
therapeutic efficiency. Although tyrothricin has not 
been found thus far to be toxic towards other 
animal cells which have been tested yet the pres­
ence of pus, serum, gram-negative bacteria in 
abundance and also its own hemolytic properties 
and high toxicity act as limitations to its thera­
peutic applicability. On account of these peculiari- 
tes tyrothricin (and also gramicidin and tyrocidin) 
will probably be restricted in their employment
I
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to local administration. Little-7 has reported on 
the successful use of gramicidin, locally, in bovine 
mastitis and infected ulcers.
Actinomycin A and B are two substances iso­
lated by Waksman and Woodruff28 from A. anti- 
bioticus. Actinomycin-A is highly selective as a 
bacteriostatic agent while actinomycin-B is reputed 
to be largely bactericidal. Actinomycin is antago­
nistic to many bacteria and fungi. However, be­
cause of its rapid disappearance from the blood 
stream and also its toxic action against all animal 
species its therapeutic employment will no doubt 
be limited. Its in vivo effects against streptococcus 
hemolyticus, type-1 pneumococcus and brucella 
abortus in guinea pigs are not pronounced and 
late death through respiratory failure is not in­
frequently elicited.
Tyrothricin and actinomycin-A inhibit fibrolysis 
and plasma coagulation by beta-hemolytic strepto­
coccus cultures or their supernatant fluids, Neter.29 
Another antibiotic, streptothricin derived from a 
soil actinomyces has been found to be active both 
in vivo and in vitro in tests with brucella abortus. 
Because of its low-grade toxicity for animal tis­
sues this antibiotic gives promise as an effective 
agent for treating brucelliasis in animals.
Another interesting antimicrobiotic is strepto- 
myces closely related to actinomyces griseus, which 
is presently being investigated. Streptomycin re­
sembles streptothricin as to solubility in water, the 
manner of its isolation, its reproduction in labora­
tory culture; its high selectivity against gram-nega­
tive organisms, and its limited toxicity to the 
animal organism. The most notable differences are 
in their bacteriostatic spectra and their quanti­
tative action.
Lactenin and lysozyme are good samples of anti- 
microbic substances derived from sources some­
what different from the agents mentioned above. 
The former is obtained from the albumin fraction 
of milk; the latter is an enzyme present in a large 
variety of animal tissues, and possibly plants also. 
Jones and Simms30 have attributed to lactenin 
great activity against streptococci; and lysozyme, 
while especially active against non-pathogens causes 
lysis of many species of bacteria, according to the 
report of Meyer and his co-workers.31 These work­
ers indicate that its action is due to the hydrolysis 
of some mucopolysaccharide which constitutes an 
integral part of the structure of the susceptible
cell. A successful attack, not necessarily upon the 
cell proper but upon those agencies which as 
products or components of the cell condition its 
pathogenicity might turn out to be of an order 
of clinical importance equal to a direct attack. 
Thus Dubos5 observes: "there have been obtained 
from saprophytic micro-organisms, also from leech 
extract, enzymes capable of hydrolyzing the cap­
sular polysaccharides of pneumococci and strepto­
cocci." And he notes that whereas the viability, 
metabolism or growth in vivo of these organisms 
is not affected by the destruction of their cap­
sules yet their removal deprives the bacteria of 
their surface protection as well as their essential 
pathogenicity and renders them thereby more vul­
nerable to the phagocytes of the body. Of lyso­
zyme, Dubos5 has this to say specifically: "Lyso­
zyme attacks a chemical component so essential 
to the integrity of cellular structure that it causes 
lysis and death of the susceptible cells. To affect 
the pathogenic career of an infectious micro-or­
ganism, however, it may be sufficient to attack a 
product of the micro-organism not essential to its 
vital activities but of critical importance to its 
pathogenicity." With such a thought in mind the 
conceptual difference between an agent that is 
bacteriostatic and one that is bactericidal appears 
to be merely academic.
MECHANISMS OF ACTION
Our knowledge of the mode of action of the 
sulfonamide group of drugs, although limited, is 
yet considerably in advance of our information on 
that of the penicillin group. We shall, therefore, 
begin with a consideration of the former.
The close similarity between the structural con­
figurations of para aminobenzoic acid and the sul­
fonamides put over against their opposing dynamic 
action has served to open up the investigation 
into the mechanism of sulfonamide action.
In 1942 Thomas and Dingle32 confirming the 
findings of Wood33 published a report on the 
"Protection of Mice against Meningococcal Infec­
tion by Sulfadiazine and Inhibition of Protection 
by Para aminobenzoic Acid." These investigators 
found that in appropriate doses sulfadiazine furn­
ishes adequate protection against a virulent strain 
of Group-1 meningococcus but that this protec­
tive action could be inhibited by repeated doses 
of para aminobenzoic acid. Similarly Maier and
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Riley34 reported that para aminobenzoic acid is 
capable of completely inhibiting the antiplas- 
modial effect of sulfanilamide in rhesus monkeys. 
They were also emphatic in stating that para 
aminobenzoic acid exerts no inhibiting action what­
ever against the antimalarial effects of quinine or 
atebrine. A definite antagonism was thus demon­
strated between these two chemical substances.
The accepted explanation is that bacteriostasis 
is brought about in sulfonamide medication 
through an interference which the drug imposes 
in the course of the normal metabolic processes 
of the invading cells. Cells of the living bacteria 
are equipped with a complex enzyme system by 
means of which they undergo a series of chemical 
reactions on or near their surfaces in meeting their 
nutritional needs. Para aminobenzoic acid, a basic 
component of the synthetic local anesthetics of 
the cocaine series, appears to be necessary for the 
growth of the hemolytic streptococcus. This state­
ment is also true, probably, for all organisms that 
show susceptibility to the action of the sulfona­
mide group of compounds. When introduced into 
the para aminobenzoic acid, compete with the 
latter and largely replace it in the enzymatic pro­
cess. By so doing they probably prevent the com­
pletion of the reaction and thereby arrest the or­
ganisms in their growth.
Whereas the sulfonamides interfere with bac­
terial growth, penicillin seems to interfere with 
cellular division at some stage in this process. 
However, neither agent seems capable of arrest­
ing the susceptible organisms in their other vital 
functions; for both of them when given in concen­
trations even considerably in excess of the optimal 
for the causation of inhibition of growth and di­
vision fail to cause rapid death. Moreover, after 
complete inhibition of their growth and propa­
gation, if these susceptible organisms are trans­
ferred to an auspicious environment upon a new 
culture medium they promptly revive and proceed 
to grow and divide as readily as control cells. The 
sulfonamides and penicillin for this reason, then, 
are referred to as bacteriostatic in action. But since 
they tend to spare the host by their bacteriostatic 
action they are said by some workers to be also 
bactericidal, especially in large doses. In fact, in 
addition to this bacteriostatic effect, investigators 
of high repute like Levaditi and Vaisman33 and 
Domagk7 speaking for the sulfonamides have at­
tributed to these compounds the capacity to stimu­
late the phagocytic powers of the body. On the 
other hand such observers as Long, Bliss and 
Feinstone36 would be inclined to deny them any 
such action. Regarding this moot question the 
opinion expressed by Marshall36 seems to be 
gaining general acceptance. He says . . . 'The first 
effect in the cure of an infected animal or man is 
a direct action of the drug on the parasite rather 
than a stimulation of defense mechanisms of the 
host. Such defense mechanisms may, however, op­
erate as the final stage in the chemotherapeutic 
process.”
Finally, individual specificities must not be 
overlooked. For example, gramicidin, tyrocidin, 
tyrothricin and actinomycin, especially, are highly 
toxic to certain body cells. These antibiotics will, 
therefore, always be limited in their therapeutic 
scope. But by contrast penicillin and, to a less ex­
tent streptomycin and streptothricin will continue 
to be available for wide systemic employment.
No attempt has been made to make complete 
coverage of therapeutic possibilities for these two 
groups of chemical compounds. However it would 
be well-nigh unpardonable were we to omit the 
fact that although the sulfonamides have exhibited 
no action whatever against the treponema pallidum 
penicillin has. Mahoney37 reporting to the Ameri­
can public Health Association states that as a re­
sult of penicillin treatment there was a rapid dis­
appearance of the spirochete from superficial le­
sions and also the resolution of early lesions. This 
observation has been verified by Bloomfield, Rantz 
and Kirby24 who add that "condylomas have be­
come free of treponemes in approximately twelve 
to twenty hours” and that "immediate results com­
parable to those obtained with full doses of ars- 
phenamine can be achieved.” Treatment for syphi­
lis with penicillin is now being undertaken under 
the supervision of committees of the National Re­
search Council and the Committee on Medical Re­
search of the Office of Scientific Research and De­
velopment. The final verdict regarding the ques­
tion of its permanent addition to the current anti­
syphilitic armamentarium lies in the Jap of time.
The most interesting features which this study 
into the chemotherapy of the sulfonamides and 
the penicillin group of compounds reveals are the 
scope of their therapeutic applicability; their spar­
ing action on the cells and tissues of the host; and 
their predilection for the organisms that cause in­
fection. Bearing these facts in mind it seems en­
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tirely within the purview of the constructive scien­
tific imagination to envisage for the therapeutics 
of tomorrow a mine of chemotherapeutic agents 
capable of covering the entire category of patho­
gens that attack and afflict the human body and 
its protection against the many ailments which they 
cause.
SUMMARY
1. An attempt.has been made to set forth the 
differences between the essentially physical and the 
essentially chemical mechanism of action of drugs. 
The first category is illustrative of the action of 
alkaloids, which bombard and escape unscathed and 
unchanged. The second is of the glycosides which 
effect molecular changes in all the affected com­
ponents in the course of a typical reaction.
2. Since the problem of antisepsis is better 
known than chemotherapy this knowledge of 
antisepsis has been employed by way of an intro­
duction to our approach to chemotherapy. Ehr­
lich’s idea of chemotherapeutic agents was the ef­
fecting of speedy sterilization. Since this first pro­
posal, however, the truly definitive action of chemo­
therapeutic agents is bacteriostasis, first; and steri­
lization, later.
3. With this in mind the actions of two of the 
newer types of chemotherapeutic agents, the sul- 
fofiamides and the penicillin group of compounds, 
has been set forth with pertinent illustrations of 
their scopes and specifications.
4. The mechanisms of their action are discussed 
and illustrated. The sulfonamides seem to retard 
growth; penicillin group to inhibit cell division.
5. On the basis of their therapeutic range; the 
ability of most of them to act on the invader while 
sparing the host; and their remarkable antagon­
ism with respect to infectious micro-organisms, the 
warfare against infectious diseases looks bright.
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